Djordje Müsil

Merck (Germany) — Germany

Computer Science · Physical Sciences

32h-index4.4kcitations114works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(20), Peptidase Inhibition and Analysis(18), Ubiquitin and proteasome pathways(16), Protein Structure and Dynamics(15), Heat shock proteins research(14)

Publications114 total

Pushing the limits of hydrogen/deuterium exchange mass spectrometry to study protein:fragment low affinity interactions
Communications Chemistry·2025Open Access
Discovery of ART5537: A Potent and Selective Small-Molecule Probe for EXO1
Journal of Medicinal Chemistry·2025
Phenotypic Hit Identification and Optimization of Novel Pan-TEAD and Subtype-Selective Inhibitors
Journal of Medicinal Chemistry·2025· 1 cited
MoA Studies of the TEAD P-Site Binding Ligand MSC-4106 and Its Optimization to TEAD1-Selective Amide M3686
Journal of Medicinal Chemistry·2024· 9 cited
On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality
Protein Science·2024· 17 citedOpen Access
Discovery of reversible and covalent TEAD 1 selective inhibitors MSC-1254 and MSC-5046 based on one scaffold
Bioorganic & Medicinal Chemistry Letters·2024· 5 citedOpen Access
Data from M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models
2024Open Access
Supplementary Data from M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models
2024Open Access
Supplementary Data from M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models
2024Open Access
Data from M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models
2024Open Access
Contributors
Elsevier eBooks·2023
Methionine aminopeptidases
Elsevier eBooks·2023· 5 cited
CCDC 2150876: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
CCDC 2240817: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
CCDC 2257777: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
CCDC 2257778: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
Discovery of quinazoline HPK1 inhibitors with high cellular potency
Bioorganic & Medicinal Chemistry·2023· 13 citedOpen Access
Discovery of Cycloalkyl[<i>c</i>]thiophenes as Novel Scaffolds for Hypoxia-Inducible Factor-2α Inhibitors
Journal of Medicinal Chemistry·2023· 7 citedOpen Access
Selective Wee1 Inhibitors Led to Antitumor Activity <i>In Vitro</i> and Correlated with Myelosuppression
ACS Medicinal Chemistry Letters·2023· 17 citedOpen Access
Discovery of HPK1 Inhibitors with High Cellular Potency
SSRN Electronic Journal·2023Open Access
page 1 of 6Next →

Frequent Co-authors

Felix Rohdich(13), Christina Esdar(11), Hans‐Peter Buchstaller(9), Paul Czodrowski(9), Ulrich Grädler(9), Ansgar Wegener(9), Richard Schneider(9), Birgitta Leuthner(8), Kai Schiemann(8), Dániel Schwarz(8), Timo Heinrich(8), Dirk Wienke(7), Jörg Bomke(7), Jakub Gunera(6), Mireille Krier(6), Michael Busch(6), Wolfram Bode(5), Dieter Dorsch(5), Theresa Johnson(5), Andrea Unzue Lopez(5)